Repligen (RGEN) - Cash on Hand

Cash on Hand as of December 2025 : HK$6.01 Billion

According to Repligen 's latest financial reports the company has HK$6.01 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year	Cash on Hand	Change
2025-12-31	HK$5.97 B	1.58%
2024-12-31	HK$5.87 B	0.2%
2023-12-31	HK$5.86 B	20.4%
2022-12-31	HK$4.87 B	3.51%
2021-12-31	HK$4.70 B	-15.33%
2020-12-31	HK$5.56 B	35.12%
2019-12-31	HK$4.11 B	171.13%
2018-12-31	HK$1.51 B	11.8%
2017-12-31	HK$1.35 B	23.48%
2016-12-31	HK$1.09 B	97.63%
2015-12-31	HK$0.55 B	22.7%
2014-12-31	HK$0.45 B	-5.12%
2013-12-31	HK$0.47 B	53.91%
2012-12-31	HK$0.31 B
2011-03-31	HK$0.38 B	-6.46%
2010-03-31	HK$0.41 B	8.98%
2009-03-31	HK$0.37 B	-2.26%
2008-03-31	HK$0.38 B	119.12%
2007-03-31	HK$0.17 B	20.21%
2006-03-31	HK$0.14 B	9.62%
2005-03-31	HK$0.13 B	23.48%
2004-03-31	HK$0.10 B	-10.28%
2003-03-31	HK$0.12 B	-25.5%
2002-03-31	HK$0.16 B	-12.93%
2001-03-31	HK$0.18 B	-29.54%
2000-03-31	HK$0.26 B	935.59%
1999-03-31	HK$25.58 M	-29.76%
1998-03-31	HK$36.42 M	34.3%
1997-03-31	HK$27.11 M	-49.18%
1996-03-31	HK$53.36 M

Cash on Hand for similar companies or competitors

Company	Cash on Hand	differencediff.	Country
Pfizer PFE	HK$106.48 B	1,671.17%	🇺🇸 USA
Thermo Fisher Scientific TMO	HK$79.13 B	1,216.39%	🇺🇸 USA
General Electric GE	HK$97.05 B	1,514.32%	🇺🇸 USA
Bristol-Myers Squibb BMY	HK$83.58 B	1,290.39%	🇺🇸 USA
Sangamo Therapeutics SGMO	HK$0.23 B	-96.14%	🇺🇸 USA
Novavax NVAX	HK$5.75 B	-4.24%	🇺🇸 USA
Neurocrine Biosciences NBIX	HK$11.59 B	92.85%	🇺🇸 USA
Bio-Techne TECH	HK$1.35 B	-77.48%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	HK$12.22 B	103.30%	🇺🇸 USA
Charles River Laboratories CRL	HK$1.67 B	-72.15%	🇺🇸 USA

Repligen (RGEN) - Cash on Hand

Cash on Hand as of December 2025 : HK$6.01 Billion

Repligen - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Cash on Hand for similar companies or competitors

What is the market capitalization of a company?

DISCLAIMER

Contact

Links